Literature DB >> 1032070

A double blind comparison of buprenorphine and morphine in conscious subjects following administration by the intramuscular route.

J M Orwin, J Orwin, M Price.   

Abstract

Buprenorphine was studied to determine the respiratory depressant effect in a double blind comparison with morphine. Buprenorphine produced a more prolonged displacement of the carbon dioxide response curve than morphine. Because of the marked difference in the time effect curves the relative potency was determined at the time of peak effect--3 hours post-administration for buprenorphine (0.15 and 0.3 mg) and 1 hour post administration for morphine (5 and 10 mg). The data from the subjects who received higher doses of buprenorphine (0.6 and 1.2 mg) showed that there was a linear relationship over the dose range 0.15-1.2 mg in terms of respiratory depression.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1032070

Source DB:  PubMed          Journal:  Acta Anaesthesiol Belg        ISSN: 0001-5164


  5 in total

1.  Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs.

Authors:  M J Rance
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  Side-effects of mixed agonist-antagonist analgesics used in sequential anaesthesia.

Authors:  C Devaux; P Schoepffler; J P Gauthier-Lafaye
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 3.  Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

4.  Psychomotor, respiratory and neuroendocrinological effects of buprenorphine and amitriptyline in healthy volunteers.

Authors:  U Saarialho-Kere; M J Mattila; M Paloheimo; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 5.  Management of chronic pain in the elderly: focus on transdermal buprenorphine.

Authors:  Nalini Vadivelu; Roberta L Hines
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.